StockData

Drugs Made In America Acquisition II Corp. (DMII) stock

DMIINasdaqBlank ChecksFiscal year ends December 31Also trades as DMIIR, DMIIU
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.24+0.00 (+0.05%)

Close on Nov 17, 2026Market cap $140.36MP/E –Yield –

Drugs Made In America Acquisition II total assets

Total assets on the balance sheet at the end of each period.

Drugs Made In America Acquisition II's total assets was $518.72M at Sep 30, 2026. For fiscal 2025 it was $504.96M, up 365643.3% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$504.96M+365643.3%
FY2024Dec 31, 2024$138.06K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$518.72M+3.5%
Q2 FY2026Jun 30, 2026$514.10M+372263.7%
Q1 FY2026Mar 31, 2026$509.73M–
Q4 FY2025Dec 31, 2025$504.96M–
Q3 FY2025Sep 30, 2025$501.01M–
Q4 FY2024Dec 31, 2024$138.06K–

More Drugs Made In America Acquisition II figures

See a number that looks wrong?